首页 | 本学科首页   官方微博 | 高级检索  
     

舒血通联合氯吡格雷治疗80岁以上高龄脑梗死60例临床评价
引用本文:焦信忠,刘廷敏,李晶晶. 舒血通联合氯吡格雷治疗80岁以上高龄脑梗死60例临床评价[J]. 中外医疗, 2016, 0(18): 140-141. DOI: 10.16662/j.cnki.1674-0742.2016.18.140
作者姓名:焦信忠  刘廷敏  李晶晶
作者单位:茌平县人民医院神经内科,山东茌平,252100
摘    要:目的:分析疏血通联合氯吡格雷治疗高龄脑梗死的临床疗效。方法随机择取该院2015年1—10月收治的脑梗死患者60例,分为常规组与实验组,每组30例,比较治疗效果。结果比较两组患者的血液流变学指标水平均差异有统计学意义,P﹤0.05。结论高龄脑梗死患者采用疏血通+氯吡格雷临床治疗更为安全有效。

关 键 词:高龄脑梗死  氯吡格雷  疏血通

Shuxietong with Clopidogrel Therapy Over 80 - years - old Cerebral In-farction, 60 Cases of Clinical Evaluation
Abstract:Objective To analyze ShuXieTong combined therapy with clopidogrel - the clinical curative effect of cerebral infarction. Methods In our hospital from January 2015 to October 2015, 60 patients with cerebral infarction, divided into normal group and experimental group, 30 cases in each group, compare the efficacy of treatment. Results Compare the hemorheology index level of two groups of patients have significant difference, (P﹤ 0.05). Conclusion Elderly patients with cerebral infarction using ShuXieTong+clopidogrel is more safe and effective clinical treatment.
Keywords:Senile cerebral infarction  Clopidogrel  ShuXieTong
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号